COVALON TECHNOLOGIES LTD (COV.CA) Stock Price, Forecast & Analysis
Canada - TSX-V:COV - CA22282D3022 - Common Stock
COV.CA Key Statistics, Chart & Performance
The current stock price of COV.CA is 2.25 CAD. In the past month the price increased by 8.53%. In the past year, price decreased by -33.43%.
COV.CA Latest News, Press Relases and Analysis
COV.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 423.27M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 428.58M | ||
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 317.26M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 161.16M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 125.11M | ||
| NRX.CA | NUREXONE BIOLOGIC INC | N/A | 56.93M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 36.27M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 26.23M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 28.67M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 17.48M | ||
| MPH.CA | MEDICURE INC | N/A | 12.11M | ||
| CSCI.CA | COSCIENS BIOPHARMA INC | N/A | 11.60M |
Related stock screener links
About COV.CA
Company Profile
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm's solutions are designed for patients and made for care providers. The firm leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The firm has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.
Company Info
COVALON TECHNOLOGIES LTD
1660 Tech Avenue, Unit 5
Mississauga ONTARIO L4W 5S7 CA
CEO: Simon Smith
Employees: 41
Phone: 18777116055
COVALON TECHNOLOGIES LTD / COV.CA FAQ
Can you describe the business of COVALON TECHNOLOGIES LTD?
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm's solutions are designed for patients and made for care providers. The firm leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The firm has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.
What is the stock price of COVALON TECHNOLOGIES LTD today?
The current stock price of COV.CA is 2.25 CAD. The price decreased by -0.88% in the last trading session.
What is the dividend status of COVALON TECHNOLOGIES LTD?
COV.CA does not pay a dividend.
What is the ChartMill rating of COVALON TECHNOLOGIES LTD stock?
COV.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Would investing in COVALON TECHNOLOGIES LTD be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on COV.CA.
What is the market capitalization of COV stock?
COVALON TECHNOLOGIES LTD (COV.CA) has a market capitalization of 61.70M CAD. This makes COV.CA a Micro Cap stock.
COV.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to COV.CA. When comparing the yearly performance of all stocks, COV.CA is a bad performer in the overall market: 92.64% of all stocks are doing better.
COV.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to COV.CA. COV.CA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
COV.CA Financial Highlights
Over the last trailing twelve months COV.CA reported a non-GAAP Earnings per Share(EPS) of 0.08. The EPS increased by 350.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7% | ||
| ROA | 6.56% | ||
| ROE | 7.78% | ||
| Debt/Equity | 0.02 |
COV.CA Forecast & Estimates
9 analysts have analysed COV.CA and the average price target is 3.83 CAD. This implies a price increase of 70% is expected in the next year compared to the current price of 2.25.
For the next year, analysts expect an EPS growth of -92.31% and a revenue growth 7.74% for COV.CA